Advertisement

Topics

Deals this week: Milestone Pharmaceuticals, Homology Medicines, Ultragenyx Pharmaceutical

19:00 EDT 3 Aug 2017 | Net Resources International

Canadian cardiovascular drug development company Milestone Pharmaceuticals has secured $55m through a series C funding round led by Novo Holdings.

Original Article: Deals this week: Milestone Pharmaceuticals, Homology Medicines, Ultragenyx Pharmaceutical

NEXT ARTICLE

More From BioPortfolio on "Deals this week: Milestone Pharmaceuticals, Homology Medicines, Ultragenyx Pharmaceutical"

Quick Search
Advertisement
 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...